John Trizzino, EVP, CCO and CBO at NOVAVAX INC (NVAX), sold 11,739 shares at $216.21 ($2.5M) on 2021-09-28, disclosed to the SEC on 2021-09-29.
Open-market sale of $2.5M NVAX by EVP, CCO and CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $203.26 | 839 | $171K | 6.9% |
| 2 | $203.26 | 839 | $171K | 6.9% |
| 3 | $204.12 | 1,141 | $233K | 9.4% |
| 4 | $204.12 | 1,141 | $233K | 9.4% |
| 5 | $205.25 | 1,452 | $298K | 12.1% |
| 6 | $206.30 | 990 |
| $204K |
| 8.3% |
| 7 | $207.32 | 382 | $79K | 3.2% |
| 8 | $207.32 | 382 | $79K | 3.2% |
| 9 | $208.46 | 312 | $65K | 2.6% |
| 10 | $208.46 | 312 | $65K | 2.6% |
| 11 | $209.57 | 112 | $23K | 1.0% |
| 12 | $211.45 | 100 | $21K | 0.9% |
| 13 | $213.11 | 30 | $6K | 0.3% |
| 14 | $214.65 | 318 | $68K | 2.8% |
| 15 | $214.65 | 318 | $68K | 2.8% |
| 16 | $216.21 | 247 | $53K | 2.2% |
| 17 | $216.21 | 247 | $53K | 2.2% |
| 18 | $218.13 | 226 | $49K | 2.0% |
| 19 | $219.26 | 421 | $92K | 3.7% |
| 20 | $219.26 | 421 | $92K | 3.7% |
| 21 | $220.22 | 49 | $11K | 0.4% |
| 22 | $222.86 | 255 | $57K | 2.3% |
| 23 | $222.86 | 255 | $57K | 2.3% |
| 24 | $224.24 | 148 | $33K | 1.3% |
| 25 | $228.25 | 323 | $74K | 3.0% |
| 26 | $228.25 | 323 | $74K | 3.0% |
| 27 | $230.00 | 156 | $36K | 1.5% |
| Total | $210.14 avg | 11,739 | $2.5M | 100% |
| Filing → |
| NVAX | SELL | 2021-09-15 | $7.0M | — | Filing → |
| NVAX | SELL | 2021-05-07 | $802K | — | Filing → |
| NVAX | SELL | 2021-04-07 | $1.2M | — | Filing → |